HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

In vitro and in vivo characterization of a novel nonsteroidal, species-specific progesterone receptor modulator, PRA-910.

Abstract
The progesterone receptor (PR) is an important regulator of female reproduction. Consequently, PR modulators have found numerous pharmaceutical utilities in women's reproductive health. In the process of identifying more receptor-specific and tissue-selective PR modulators, we discovered a novel nonsteroidal, 6-aryl benzoxazinone compound, PRA-910, that displays unique in vitro and in vivo activities. In a PR/PRE reporter assay in COS-7 cells, PRA-910 shows potent PR antagonist activity with an IC50 value of approximately 20 nM. In the alkaline phosphatase assay in the human breast cancer cell line T47D, PRA-910 is a partial progesterone antagonist at low concentrations and is also an effective PR agonist at higher concentrations (EC50 value of approximately 700 nM). PRA-910 binds to the human PR with high affinity (Kd = 4 nM) and was previously shown to exhibit greater than 100-fold selectivity for the PR versus other steroid receptors. In the adult ovariectomized rat, PRA-910 is a potent PR antagonist. It inhibits progesterone-induced uterine decidual response with an ED50 value of 0.4 mg/kg, p.o., and reverses progesterone suppression of estradiol-induced complement C3 expression with potency similar to RU-486. In the nonhuman primate, however, PRA-910 is a PR agonist. The effect on endometrial histology strongly resembles that of progesterone. This unique compound also suppresses estradiol-induced epithelial cell proliferation and both estrogen and progesterone receptor expression in the uterine endometrium as a PR agonist would. In summary, PRA-910 is a structurally and biologically novel selective PR modulator with either PR agonist or antagonist activity, depending on context, concentration, and species.
AuthorsZ Zhang, S G Lundeen, O Slayden, Y Zhu, J Cohen, T J Berrodin, J Bretz, S Chippari, J Wrobel, P Zhang, A Fensome, R C Winneker, M R Yudt
JournalErnst Schering Foundation symposium proceedings (Ernst Schering Found Symp Proc) Issue 1 Pg. 171-97 ( 2007) Germany
PMID18540573 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Heterocyclic Compounds, 2-Ring
  • Nitriles
  • PRA-910
  • Receptors, Progesterone
Topics
  • Animals
  • COS Cells
  • Cell Line, Tumor
  • Chlorocebus aethiops
  • Female
  • Heterocyclic Compounds, 2-Ring (metabolism, pharmacology)
  • Humans
  • In Vitro Techniques
  • Male
  • Nitriles (metabolism, pharmacology)
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Progesterone (drug effects, metabolism)
  • Species Specificity
  • Two-Hybrid System Techniques

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: